about
Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1Plasma high density lipoproteins. Metabolism and relationship to atherogenesis.Effect of pindolol on serum lipids and lipid metabolizing enzymes.Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.Liver-specific phospholipid transfer protein deficiency reduces high-density lipoprotein and non-high-density lipoprotein production in mice.Adrenergic mechanisms in control of plasma lipid concentrations.C-terminus of apolipoprotein A-I removes phospholipids from a triolein/phospholipids/water interface, but the N-terminus does not: a possible mechanism for nascent HDL assembly.The contribution of individual and pairwise combinations of SNPs in the APOA1 and APOC3 genes to interindividual HDL-C variabilityAlcohol and high-density lipoproteins.Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia.Dehydroepiandrosterone and related steroids induce multilamellar lipid structures in cultured human endothelial cells.Regulation of serum apolipoprotein E metabolism: role of chylomicron metabolismAbnormalities in very low, low and high density lipoproteins in hypertriglyceridemia. Reversal toward normal with bezafibrate treatmentFitness, Heart Disease, and High-Density Lipoproteins: A Look at the Relationships.Automation of PRM-dependent D3-Leu tracer enrichment in HDL to study the metabolism of apoA-I, LCAT and other apolipoproteins.Use of total cholesterol/albumin ratio as an alternative to high density lipoprotein cholesterol measurement.Serum amyloid P component prevents high-density lipoprotein-mediated neutralization of lipopolysaccharide.A review of plasma apolipoprotein A-I interactions with phosphatidylcholines.Plasma lipid alterations in patients with chronic renal disease.Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.In vitro remodelling of plasma lipoproteins in whole plasma by lipoprotein lipase in primary and secondary hypertriglyceridaemia.A Computer-Oriented Diabetes Clinic: Assessing the Benefits of Diabetic Control.Effect of 20 days' bed rest on the reverse cholesterol transport system in healthy young subjects.Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.Hyperlipidemia. What is 'normal,' who should be treated and how.The acute phase response in Syrian hamsters elevates apolipoprotein serum amyloid A (apoSAA) and disrupts lipoprotein metabolism
P2860
Q33844399-516AF3A3-7F05-4963-B5D8-2F5F74A200E4Q33897743-08E123F4-2C6E-4653-AF89-25ECEAC0546AQ34257420-3AA1432B-684B-444A-893F-5AE4505B4B8AQ34450291-C4D72BE9-BED1-48B8-8F79-89A00AAAE5F2Q34651427-0D1CF772-E481-4FFF-9BD5-B1B558B53B3CQ34680124-DE299372-9286-4A58-990D-1696B316594BQ34750825-8E2EBB38-94E0-4675-889F-9D43DB662114Q35106725-160ABCA5-99E4-48FC-A18B-8BA1BB75F44AQ35222189-4B94077D-2264-4F3E-BCE2-6E888C273040Q35229134-4FEC7337-B5E2-4781-B8E0-0F48ED88A66AQ35750498-31E415FF-3099-467E-AF59-002044039968Q35811262-932E5D9F-9386-48FE-8FF2-155CE988806BQ36283340-36ECE340-EF06-4346-9C82-C689321B8F78Q36992958-283F04D0-F448-4A76-B995-50FC519CC4B6Q38911180-50DA1B67-D9CB-46D5-985A-081C183F2D41Q39174515-81F5551A-1E0F-46F3-97E6-6D492E298A21Q39512768-555F8A1B-763B-41D7-B2FC-F1575EA9477EQ39537763-AC04A112-564A-4840-96B7-8DC57179D5E6Q40214382-60852196-FCF1-4E9B-8CC9-030B6F8FECE8Q40242885-8935520A-BBBE-444B-8C44-F77493015052Q42990157-09869A27-6D2D-4CB0-9766-F7180A2E94ADQ44132543-8EAB0C31-DDC5-4C9C-90D7-CDA4F90C900EQ45976986-3F3E76A8-52F9-4310-92E5-D6E4E060F607Q47972692-56561247-327A-47D6-A15E-446B97437BBFQ50183430-965FBC85-4162-4D0B-B879-463EC26A5CC9Q51659079-0D41025A-EB66-4D60-A87E-F90E4589E46FQ58131426-C2B367AC-4B2C-4EC5-AA68-404EB1F315C2
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
Plasma high-density lipoproteins.
@en
Plasma high-density lipoproteins.
@nl
type
label
Plasma high-density lipoproteins.
@en
Plasma high-density lipoproteins.
@nl
prefLabel
Plasma high-density lipoproteins.
@en
Plasma high-density lipoproteins.
@nl
P1476
Plasma high-density lipoproteins.
@en
P2093
P304
P356
10.1056/NEJM197811302992207
P407
P577
1978-11-01T00:00:00Z